Biomarin: Yesterday, FDA Committee Meeting. Adaptimmune: CAR T Approach for Solid Tumors

In our yesterday’s article asking about how the FDA advisory committee has to vote regarding Biomarin product Kyndrisa ( drisapersen) for Duchenne muscular dystrophy. We got the answer yesterday durin...